Identification of a Racially Dimorphic Variant in the Human Platelet PAR4 Thrombin Receptor Altering Platelet Function and Pharmacologic Inhibition

被引:0
|
作者
Edelstein, Leonard C. [1 ]
Simon, Lukas M. [2 ]
Lindsay, Cory R. [1 ]
Kong, Xiango [1 ]
Montoya, Raul Teruel [1 ]
Tourdot, Benjamin E. [1 ]
Chen, Edward [2 ]
Ma, Lin [1 ]
Coughlin, Shaun R. [3 ]
Nieman, Marvin T. [4 ]
Holinstat, Michael [1 ]
Shaw, Chad [2 ]
Bray, Paul F. [1 ]
机构
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] UCSF, San Francisco, CA USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Reply to “Inhibition of platelet thromboxane receptor function by a thrombin receptor–targeted pepducin”
    Lidija Covic
    Suzanne Jacques
    Athan Kuliopulos
    Nature Medicine, 2003, 9 : 1447 - 1448
  • [32] Arg-Pro-Pro-Gly-Phe binds to the exodomain of human protease activated receptor 4 (PAR4) to prevent thrombin proteolysis and platelet activation.
    Schmaier, AH
    Pagan-Ramos, E
    Warnock, M
    Krijanovski, Y
    Hasan, AAK
    Nieman, MT
    BLOOD, 2003, 102 (11) : 776A - 777A
  • [33] Blockade of Human PAR4 in Novel Humanized Mouse Strains Supports PAR4 As a Potential Target in Stroke: Ex Vivo Demonstration of Platelet Hyperreactivity of the Thr120 Variant
    Campbell, Robert A.
    Stoller, Michelle L.
    Denorme, Frederik
    Manne, Bhanu Kanth
    Bhatlekar, Seema
    Tugolukova, Emilia A.
    Bray, Paul F.
    BLOOD, 2020, 136
  • [34] The Common PAR4 Ala120Thr Variant Has a Major Effect on Platelet Reactivity to Thrombin and These Effects Are Enhanced with PAR1 and P2Y12 Inhibition
    Whitley, Michael J.
    Vesci, Joanne
    Holinstat, Michael
    Edelstein, Leonard C.
    Bray, Paul F.
    BLOOD, 2016, 128 (22)
  • [35] THE EFFECT OF PHARMACOLOGIC INHIBITION OF PHOSPHOLIPID METHYLATION ON HUMAN-PLATELET FUNCTION
    SHATTIL, SJ
    MONTGOMERY, JA
    CHIANG, PK
    BLOOD, 1982, 59 (05) : 906 - 912
  • [36] Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance
    Gnanenthiran, Sonali R.
    Pennings, Gabrielle J.
    Reddel, Caroline J.
    Campbell, Heather
    Kockx, Maaike
    Hamilton, Justin R.
    Chen, Vivien
    Kritharides, Leonard
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (08) : 960 - 972
  • [37] Platelet PAR4 associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-kappaB signaling in human platelets
    Sheu, J. -R.
    Chen, W. -F.
    FEBS JOURNAL, 2013, 280 : 271 - 271
  • [38] Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin - Reply
    Covic, L
    NATURE MEDICINE, 2003, 9 (12) : 1447 - 1448
  • [39] Platelet response to activation of thrombin receptors, PAR1 and PAR4, is impaired in human platelets deficient in Gαq or phospholipase C-β2.
    Vaidyula, VR
    Rao, AK
    BLOOD, 2001, 98 (11) : 25A - 26A
  • [40] A Mouse Model of the PAR4 Sequence Variant P310L Shows Decreased Platelet Reactivity and Thrombosis
    Knauss, Elizabeth Ann
    Han, Xu
    De La Fuente, Maria Almudena
    Li, Wei
    Luc, Norman
    McKenzie, Steven Edward
    Nieman, Marvin T.
    BLOOD, 2023, 142